Nautilus Biotechnology, Inc. (NAUT) compared with its closest peers (CTKB, PACB, HBIO, QSI, QTRX). Peer set by Business model: Medical Devices / Life Science Tools; 10 closest by market cap; US-domiciled. First-party data.
| Company | Market Cap | P/E |
|---|---|---|
| Cytek Biosciences, Inc. (CTKB) | $605.07M | -9.7 |
| Pacific Biosciences of California, Inc. (PACB) | $380.77M | -1.0 |
| Harvard Bioscience, Inc. (HBIO) | $159.48M | -0.5 |
| Quantum-Si incorporated (QSI) | $153.94M | -2.1 |
| Quanterix Corporation (QTRX) | $147.55M | -2.5 |
| Seer, Inc. (SEER) | $111.85M | -1.4 |
| Rapid Micro Biosystems, Inc. (RPID) | $80.74M | -2.7 |
| Precipio, Inc. (PRPO) | $51.90M | -102.4 |
| Bionano Genomics, Inc. (BNGO) | $14.31M | -0.3 |
| Astrotech Corporation (ASTC) | $13.54M | -0.7 |
| Sector P/E (Technology) | 33.9 |
| Industry P/E (Measuring & Control Equipment) | 51.8 |
NAUT overview · NAUT earnings · NAUT financials · NAUT KPIs · NAUT investor relations · NAUT ownership · NAUT filings
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.